Neonatal and maternal outcomes of pregnancy with maternal cardiac disease (the NORMANDY study) : Years 2000–2014

Advanced maternal age and risk of adverse perinatal outcome among women with congenital heart disease: A nationwide register‐based cohort study

“…9 Only a single study has investigated the association between maternal age, congenital heart disease, and neonatal outcomes 28 while other studies have included maternal age as a predictor of neonatal outcomes. 3,29 Furenäs et al 28 To some extent, it is questioned whether the effect of maternal age on adverse neonatal outcome is due to biology or due to selection. 30 Advanced maternal age has been associated with a range of adverse pregnancy outcomes showing the same shape of increase in risk across different outcomes 9,26,31,32 which might indicate a biologic explanation.…”

“…In the general population, women of advanced maternal age have a higher risk of both PTB and SGA . Only a single study has investigated the association between maternal age, congenital heart disease, and neonatal outcomes while other studies have included maternal age as a predictor of neonatal outcomes . Furenäs et al did not find a higher risk among women >35 years as compared to women ≤35 years.…”

Noteworthy Literature published in 2017 for Congenital Cardiac Anesthesiologists

“…Two additional studies in France report very similar findings for maternal and neonatal outcomes. 74,75 In an effort to better understand the incidence and predictors of maternal and fetal complications in women with CHD, van Hagen and colleagues examined a worldwide registry of pregnancy and cardiac disease. 76 They report on 2742 pregnancies in women with CHD.…”

“…Two additional studies in France report very similar findings for maternal and neonatal outcomes. 74,75…”

Major adverse cardiovascular events and anaesthetic management in pregnant women with cardiac disease: a retrospective, single-centre study

“…However, recently published data concerning anaesthetic management in women with cardiac disease are scarce. 4,5 These patients, and their future children, would therefore benefit from multidisciplinary care. 1 We conducted a retrospective single-centre study from 2013 to 2017 to evaluate the prevalence and predictive factors of major adverse cardiovascular events (MACE) during pregnancy and peripartum (up to 6 weeks postpartum) in women with cardiac disease, and investigated the anaesthetic management in this population.…”